Literature DB >> 7030748

Role of various vasodepressor systems in the acute hypotensive effect of captopril in man.

P Lijnen, R Fagard, J Staessen, L J Verschueren, A Amery.   

Abstract

The acute hypotensive effect of captopril 25 mg was investigated in 26 hypertensive patients (11 with essential and 15 with renal arterial disease). Intra-arterial blood pressure was recorded continuously and arterial blood was sampled for renin, angiotensin I and II, aldosterone, kininase II, catecholamines and prostaglandins. Captopril led to an increase in plasma renin activity, active and total plasma renin concentration and angiotensin I, a decrease in plasma kininase II activity, angiotensin II, aldosterone, prostaglandins E2 and F2 alpha and no change in plasma (nor) adrenaline, dopamine and inactive renin concentration. The hypotensive effect of captopril was related to the changes in plasma angiotensin II level and inversely to the changes in prostaglandin E2; the correlation coefficients were low, respectively 0.61 and -0.44. It is likely that the acute hypotensive effect of captopril to some extent is related to changes in plasma angiotensin II and in prostaglandins E2 and F2 alpha. There is no evidence for a role of the adrenergic systems in the hypotensive response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030748     DOI: 10.1007/bf00554659

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects.

Authors:  V S Murthy; T L Waldron; M E Goldberg
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

2.  Radioimmunoassay of plasma prostaglandins A, E and F alpha.

Authors:  P J Lijnen; A K Amery; J Huysecom
Journal:  Arch Int Physiol Biochim       Date:  1979-08

3.  Impaired renal prostaglandin E2 biosynthesis in human hypertensive states.

Authors:  S Y Tan; E Bravo; P J Mulrow
Journal:  Prostaglandins Med       Date:  1978-07

4.  Radioimmunoassay of the A prostaglandins.

Authors:  R M Zusman; B V Caldwell; L Speroff; H R Behrman
Journal:  Prostaglandins       Date:  1972-07

5.  Direct radioimmunoassay of plasma aldosterone in normal subjects.

Authors:  P Lijnen; A Amery; R Fagard; P Corvol
Journal:  Clin Chim Acta       Date:  1978-03-15       Impact factor: 3.786

6.  Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Authors:  C I Johnston; J A Millar; B P McGrath; P G Matthews
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

7.  Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.

Authors:  A Amery; L Billiet; A Boel; R Fagard; T Reybrouck; J Willems
Journal:  Am Heart J       Date:  1976-05       Impact factor: 4.749

8.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

9.  The effect of angiotensin I converting enzyme inhibitor (SQ 20881) on the release of prostaglandins by rabbit kidney, in vivo.

Authors:  E J Johns; R Murdock; B Singer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

10.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.